Komori
Governance4886ASKA Pharmaceutical Holdings Co.,Ltd.Pharmaceuticals

Articles of Incorporation 2026/06/25

The Articles of Incorporation were amended as of 24 June 2026. However, the document does not provide a comparison explaining which provisions were changed or how they were changed.

Worth reading
73In focus
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee
Number of directorsUp to 14 directors (of whom the number of outside directors is Not disclosed)
Committee1
Audit and Supervisory Committee
Changes this time

The document states that the Articles of Incorporation were amended on 24 June 2026, but the specific changes from the previous report are Not disclosed

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee
Number of directorsUp to 14 directors (of whom the number of outside directors is Not disclosed)
CommitteeAudit and Supervisory Committee (proportion of outside members: Not disclosed)
Changes this timeThe document states that the Articles of Incorporation were amended on 24 June 2026, but the specific changes from the previous report are Not disclosed
Items this document does not state (4)
Number of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The document does not state the reason for the amendment to the Articles of Incorporation.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Articles of Incorporation 2026/06/25 | ASKA Pharmaceutical Holdings Co.,Ltd. (4886) timely disclosure | Komori